Termination of Royalties Sample Clauses

Termination of Royalties. Royalties under Section 4.1, 4.2, or 4.4 will be due until the later of (i) ten years from the first commercial sale of Products in any country or (ii) on a country-by-country basis, the expiration of the last-to-expire patent within the Licensed Technology covering the Products in such country.
AutoNDA by SimpleDocs
Termination of Royalties. The obligation. to pay royalties for Licensed Products payable under this Agreement shall be terminated for a patent in the event that the United States Patent and Trademark Office or a court of competent jurisdiction holds that a patent under the Licensed Patent Rights is invalid and/or unenforceable, in a decision from which no further rights of appeal are available, and when such event occurs no further royalties shall be due under that patent.
Termination of Royalties. Subject to the other provisions of this SCHEDULE 5, in the event of a Change in Control of Aironet (defined in Section 7.1 of this SCHEDULE 5), other than as a result of (i) a bona fide, firm commitment, underwritten, public offering of Aironet stock, or (ii) a spin-off, a dividend or any other distribution of Aironet stock by Telxon to its stockholders:
Termination of Royalties. The royalty obligations set forth in Section 4.3 of the Sublicense Agreement, pursuant to which Inpharzam is to have made royalty payments to Sheffield, are hereby terminated. Any royalty obligations continuing between the parties from and after the date of this Amendment are set forth in Section 16 of this Amendment. The provisions of Sections 4.4, 4.5, 4.6, 4.7 and 4.8 are hereby amended so that they shall be deemed to apply only to the payment obligations of Sheffield to Inpharzam set forth in Section 16 of this Amendment.
Termination of Royalties. The respective obligations on the part of CCI and the Manager to pay royalties pursuant to Sections 2(a) and 3(a) shall terminate immediately upon any dissolution of the Venture other than by virtue of its merger, amalgamation or consolidation with another corporation or entity or the sale of all or substantially all of its assets to another person or entity.
Termination of Royalties. Reference is made to that certain Assignment of Technology, dated March 2, 1992, between Employee and the Company as amended by that certain Addendum Agreement, executed as of December 2, 1996, between Employee and the Company (collectively, the “Assignment”). Employee agrees that the royalty provisions of the Assignment are hereby terminated, including all requirements that the Company pay any royalties to Employee for any technology assigned to the Company pursuant to the Assignment or for any new technologies developed by Employee and other improvements provided or anticipated to be provided by Employee, and including any provisions requiring reporting or information regarding technology assigned to the Company pursuant to the Assignment.
Termination of Royalties. Royalties payable under Section 3.2, offset as provided in Section 3.3 or reduced as provided in Section 3.5, and payments payable under Section 3.7, will be due on a Product-by-Product and country-by-country basis until the later of (i) ten (10) years from the first commercial sale of such Product in such country or (ii) the expiration of the last-to-expire patent containing a Valid Claim covering the Product in such country.
AutoNDA by SimpleDocs
Termination of Royalties. The obligation to pay royalties for Licensed Products payable under this Agreement shall be terminated for a patent in the event that the United States Patent and Trademark Office or a court of competent jurisdiction holds that a patent under the Licensed Patent Rights is invalid and/or unenforceable, in a decision from which no further rights of appeal are available, and when such event occurs no further royalties shall be due under that patent. The obligation to pay royalties for Licensed Products payable under this agreement shall also be terminated as to any specific Licensed Patent Right when that specific patent expires normally or due to non-payment of a maintenance fee or annuity to the appropriate Patent Office. Notice shall be provided by Licensor to Licensee of any events which affect Licensee's obligation to pay royalties.

Related to Termination of Royalties

  • Payment of Royalties To the best of Seller’s knowledge, all royalties and in-lieu royalties with respect to the Assets which accrued or are attributable to the period prior to the Effective Time have been properly and fully paid, or are included within the suspense amounts being conveyed to Buyer pursuant to Section 11.4.

  • Payment of Royalty If the Optionor and Optionee have formed the Joint Venture under Article 4.1 hereof, then until either the Optionee or Optionor ceases to have any interest in the Joint Venture and the Property, the Optionee and Optionor shall pay their proportionate shares(based on their respective undivided interests in the Joint Venture) of any royalty payable to any governmental body.

  • Duration of Royalty Obligations The royalty obligations of Licensee as to each Product shall terminate on a country-by-country and product-by-product basis concurrently with the expiration of:

  • Earned Royalties Subject to of Article 7 hereof, Licensee shall pay to Licensor for the rights granted hereunder a sum equal to one and [*****] of the Net Invoice Value of Trademarked Products Sold by Licensee (the "Royalties"). The Royalties shall be remitted in accordance with Section 7.4 of this Agreement. 6.2

  • Reports; Payment of Royalty During the Term following the First Commercial Sale of a Product, Merck shall furnish to Ambrx a quarterly written report for the Calendar Quarter showing the Net Sales of all Royalty Products subject to royalty payments sold by Merck and its Related Parties in the Territory for use in the Field during the reporting period and the royalties payable under this Agreement. Reports shall be due on the [***] day following the close of each Calendar Quarter. Royalties shown to have accrued by each royalty report shall be due and payable on the date such royalty report is due. Merck shall keep complete and accurate records in sufficient detail to enable the royalties payable hereunder to be determined.

  • License of Data; Warranty; Termination of Rights A. The valuation information and evaluations being provided to the Trust by USBFS pursuant hereto (collectively, the “Data”) are being licensed, not sold, to the Trust. The Trust has a limited license to use the Data only for purposes necessary to valuing the Trust’s assets and reporting to regulatory bodies (the “License”). The Trust does not have any license nor right to use the Data for purposes beyond the intentions of this Agreement including, but not limited to, resale to other users or use to create any type of historical database. The License is non-transferable and not sub-licensable. The Trust’s right to use the Data cannot be passed to or shared with any other entity. The Trust acknowledges the proprietary rights that USBFS and its suppliers have in the Data.

  • Termination of Rights The right of first refusal granted the --------------------- Company by Section 3(b) above and the option to repurchase the Shares in the event of an involuntary transfer granted the Company by Section 3(c) above shall terminate upon the first sale of Common Stock of the Company to the general public pursuant to a registration statement filed with and declared effective by the Securities and Exchange Commission under the Securities Act. Upon termination of the right of first refusal described in Section 3(b) and the expiration or exercise of the Repurchase Option, a new certificate or certificates representing the Shares not repurchased shall be issued, on request, without the legend referred to in Section 6(a)(ii) below and delivered to Purchaser.

  • Earned Royalty In addition, Alnylam will pay Stanford earned royalties on Net Sales as follows:

  • Running Royalties Company shall pay to JHU a running royalty as set forth in Exhibit A, for each LICENSED PRODUCT(S) sold, and for each LICENSED SERVICE(S) provided, by Company or AFFILIATED COMPANIES, based on NET SALES and NET SERVICE REVENUES for the term of this Agreement. Such payments shall be made quarterly. All non-US taxes related to LICENSED PRODUCT(S) or LICENSED SERVICE(S) sold under this Agreement shall be paid by Company and shall not be deducted from royalty or other payments due to JHU. In order to insure JHU the full royalty payments contemplated hereunder, Company agrees that in the event any LICENSED PRODUCT(S) shall be sold to an AFFILIATED COMPANY or SUBLICENSEE(S) or to a corporation, firm or association with which Company shall have any agreement, understanding or arrangement with respect to consideration (such as, among other things, an option to purchase stock or actual stock ownership, or an arrangement involving division of profits or special rebates or allowances) the royalties to be paid hereunder for such LICENSED PRODUCT(S) shall be based upon the greater of: 1) the net selling price (per NET SALES) at which the purchaser of LICENSED PRODUCT(S) resells such product to the end user, 2) the NET SERVICE REVENUES received from using the LICENSED PRODUCT(S) in providing a service, or 3) the net selling price (per NET SALES) of LICENSED PRODUCT(S) paid by the purchaser. No multiple royalties shall be due or payable because any LICENSED PRODUCT(S) or LICENSED SERVICE(S) is covered by more than one claim of the PATENT RIGHTS or by claims of both the PATENT RIGHTS under this Agreement and “PATENT RIGHTS” under any other license agreement between Company and JHU. The royalty shall not be cumulative based on the number of patents or claims covering a product or service, but rather shall be capped at the rate set forth in Exhibit A.

  • Sublicense Fees Licensee will pay Sublicense Fees indicated in Section 3.1(e) of the Patent & Technology License Agreement on or before the Quarterly Payment Deadline for the Contract Quarter.

Time is Money Join Law Insider Premium to draft better contracts faster.